Results 141 to 150 of about 106,775 (245)

Review for "Injectable semaglutide and reductions in <scp>HbA1c</scp> and weight in the real‐world in people switched from alternative glucagon‐like peptide 1 receptor agonists"

, 2022
Jasjeet Singh Wasir
openalex   +1 more source

Should glucagon‐like peptide‐1 receptor agonist treatment be withheld in preoperative management?

Journal of Diabetes, 2023
Zachary Bloomgarden
doaj   +1 more source

Effects of insulin and the glucagon‐like peptide 1 receptor agonist liraglutide on the kidney proteome in db/db mice

, 2017
Leena Liljedahl, Jenny Norlin, James N. McGuire, Peter James   +3 more
openalex   +1 more source

Efficacy and Safety of Glucagon-Like Peptide 1 Receptor Agonists in Parkinson Disease: A Systematic Review and Meta-Analysis. [PDF]

Brain Behav
Raza H, Nizam B, Padaniya A, Farid MA, Nabi A, Hasan MQ, Salih M, Patel AH, Inam N, Rehman MEU, Khan U, Alsubari AMA.   +11 more
europepmc   +1 more source

Pericyte Bridging in Hyperglycemia, Alzheimer’s Disease, and Comorbid Pre-Clinical Models; A Sociotechnical Analysis of Glucagon-Like Peptide-1 Receptor Agonist Medications in the Treatment of Obesity

Tess Eluvathingal Muttikkal
openalex   +1 more source

Glucagon-like Peptide-1 Receptor Agonists in Liver Transplant Recipients: A Retrospective Cohort Study. [PDF]

Transplant Direct
Sheashaa H, Ibrahim R, Elshaer A, Pham HN, Mouhaffel R, Habib E, Abdelnabi M, Farina JM, Lester SJ, Simper D, Alsidawi S, Steidley ED, Aqel BA, Barnhill M, Kim WR, Ayoub C, Arsanjani R.   +16 more
europepmc   +1 more source

Pneumatosis intestinalis in a patient treated with a glucagon-like peptide-1 receptor agonist and prednisone. [PDF]

JCEM Case Rep
Sutton S, Ferguson Q, Gimpelevich R, Hemadeh O.   +3 more
europepmc   +1 more source

Outcomes of primary rotator cuff repair in non-diabetic patients using glucagon-like peptide-1 (GLP-1) receptor agonists: A propensity-matched analysis

J Ambrose Martino, Alexander Oles, Brandon L. Rogalski, Josef K Eichinger, Richard J Friedman   +4 more
openalex   +2 more sources

Glucagon‐Like Peptide‐1 Receptor Agonists Improve MASH and Liver Fibrosis: A Meta‐Analysis of Randomised Controlled Trials [PDF]

Alessandro Mantovani, Riccardo Morandin, Veronica Fiorio, Maria Giovanna Lando, Norbert Stefan, Herbert Tilg, Christopher D. Byrne, Giovanni Targher   +7 more
openalex   +1 more source

Sustained Action of Imapextide, A Glucagon-Like Peptide-1 Receptor Antagonist, in Healthy Volunteers.

J Clin Endocrinol Metab
Fabbrini E, Koshkina A, Hackett M, Zhao M, Thalluri K, Hompesch M, Macias A, Schneider K, D'Alessio DA, DiMarchi RD, Azoulay S.   +10 more
europepmc   +1 more source